Home
 Search
 Category
 Compounds
 Status
 Download
 Contacts
 Resources


Compound category: Benzenoids
(total 25 related compounds in database, current show from 1 to 10)
 
Compound name 2D structure Target pathogen(s) Related VF/VFcategory Max phase Reference(s)
Sepantronium bromide Depiction based on curated SMILES _ Br N N O CH 3 O H 3 C O N + N Escherichia
Salmonella		 TTSS secreted effectors
TTSS-2 secreted effectors		 Phase II trial
Preclinical (in vitro)		 El Qaidi S, et al. 2018. Front Cell Infect Microbiol; Zhu C, et al. 2021. Pathogens
Sibofimloc Depiction based on curated SMILES HO HO HO HO O OH OH HO HO O N CH 3 O Escherichia Adherence Phase II trial Chevalier G, et al. 2021. Microbiome; Reinisch W, et al. 2022. J Gastroenterol Hepatol
1-phenyl-3-[4-(phenylsulfamoyl)phenyl]thiourea Depiction based on curated SMILES NH S N H O HN O S Escherichia
Salmonella		 Regulation
QseBC		 Preclinical (in vivo)
Preclinical (in vivo)		 Rasko DA, et al. 2008. Science
2-benzyl-8-cyclopropyl-7-(1-naphthylmethyl)-5-oxo-thiazolo[3,2-a]pyridine-3-carboxylic acid Depiction based on curated SMILES O N OH O S Escherichia Type 1 fimbriae; P fimbriae; S fimbriae Preclinical (in vivo) Greene SE, et al. 2014. mBio
3-[4-[(R)-hydroxy-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]phenyl]-N-methylbenzamide Depiction based on curated SMILES O OH OH HO HO H 3 C OH H O NH Escherichia Type 1 fimbriae Preclinical (in vivo) Mydock-McGrane L, et al. 2016. J Med Chem
3-[4-[(R)-hydroxy-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]-3-methylphenyl]-N-methylbenzamide Depiction based on curated SMILES O CH 3 HO OH OH OH CH 3 HO H O N H Escherichia Type 1 fimbriae Preclinical (in vivo) Mydock-McGrane L, et al. 2016. J Med Chem
3-[4-[(S)-hydroxy-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]phenyl]-N-methylbenzamide Depiction based on curated SMILES O OH HO HO OH H 3 C OH O N H Escherichia Type 1 fimbriae Preclinical (in vivo) Mydock-McGrane L, et al. 2016. J Med Chem
3-[4-[(S)-hydroxy-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]-3-methylphenyl]-N-methylbenzamide Depiction based on curated SMILES O CH 3 HO OH OH OH CH 3 HO H O N H Escherichia Type 1 fimbriae Preclinical (in vivo) Mydock-McGrane L, et al. 2016. J Med Chem
3-[4-[(S)-hydroxy-[3,4,5-tris(phenylmethoxy)-6-(phenylmethoxymethyl)oxan-2-yl]methyl]-3-methylphenyl]-N-methylbenzamide Depiction based on curated SMILES O O CH 3 NH O OH O CH 3 O O Escherichia Type 1 fimbriae Preclinical (in vivo) Mydock-McGrane L, et al. 2016. J Med Chem
Methyl 3-[4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]sulfanylphenyl]benzoate Depiction based on curated SMILES OH OH HO HO H 3 C O S O O Escherichia Type 1 fimbriae Preclinical (in vivo) Mydock-McGrane L, et al. 2016. J Med Chem
   


NOTE: for more interactive and statistic charts, please visit the JavaScript-rich interface of VFDB.



Page  1  2  3 



Back to top
2004-2025 NIPB, CAMS&PUMC